Extending the Reach of Genetic Medicine Through Next-Generation Parvovirus Vector Technology

Time: 12:00 pm
day: Day 1- Translation 1

Details:

  • A comparison of LNPs and AAVs reveals key differences in immunogenicity and toxicity, suggesting potential benefits of combined use
  • Improved targeting and uptake strategies aim to mitigate immune responses and toxicity in metabolic liver diseases
  • Overcoming delivery challenges, for LNPs to be optimized for more effective transport of therapies to liver cells

Speakers: